![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » RECEPTOPHARM SIGNS LETTER OF INTENT TO BE AQUIRED BY NUTRA PHARMA CORPORATION
RECEPTOPHARM SIGNS LETTER OF INTENT TO BE AQUIRED BY NUTRA PHARMA CORPORATION
June 19, 2006
Nutra Pharma Corp., a biotechnology company that is developing drugs for HIV and Multiple Sclerosis has announced that ReceptoPharm has signed a letter of intent to be fully acquired by Nutra Pharma Corp.
Genetic
Engineering News
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
21Oct